Nyumbani › Makroglobulinemia ya Waldenstrom › Washington
Majaribio ya kliniki ya Makroglobulinemia ya Waldenstrom katika jimbo la Washington
Masomo 7 ya Makroglobulinemia ya Waldenstrom yanatafuta washiriki katika vituo vya jimbo la Washington.
Miji katika jimbo la Washington
Maandishi rasmi ya utafiti (Kiingereza)
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Fred Hutchinson Cancer Research Center, Seattle
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT05006716Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
- Swedish Cancer Institute-Edmonds, Edmonds
- Swedish Cancer Institute-Issaquah, Issaquah
- Swedish Medical Center-First Hill, Seattle
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT04840602Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
- Medical Oncology Associates (Summit Cancer Centers) ( Site 2710), Spokane
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT04728893A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- Swedish Cancer Institute (SCI), Seattle
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07101328A Study of ARC-02 in B-cell NHL
- Summit Cancer Centers - North Spokane, Spokane
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 26 Ago 2026 · NCT07691606Study of SGR-1505 in Mature B-Cell Neoplasms
- Fred Hutchinson Cancer Center, Seattle
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 13 Feb 2026 · NCT05544019A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
- Swedish Cancer Institute, Seattle
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Okt 2025 · NCT05780034Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.